53 related articles for article (PubMed ID: 25602386)
1. Toward a better understanding of tau.
Harrington M
Lab Anim (NY); 2015 Feb; 44(2):46. PubMed ID: 25602386
[No Abstract] [Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
Delacourte A; Sautière PE; Wattez A; Mourton-Gilles C; Petter A; Bons N
C R Acad Sci III; 1995 Jan; 318(1):85-9. PubMed ID: 7757808
[TBL] [Abstract][Full Text] [Related]
4. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
5. GSK3: a possible link between beta amyloid peptide and tau protein.
Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies.
D'Onofrio G; Yu Z; Forlenza OV
Biomed Res Int; 2016; 2016():7242651. PubMed ID: 27525276
[No Abstract] [Full Text] [Related]
7. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
Zhang Q; Zhang X; Sun A
Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.
Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L
Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645
[TBL] [Abstract][Full Text] [Related]
9. A tale about tau.
Ashe KH
N Engl J Med; 2007 Aug; 357(9):933-5. PubMed ID: 17761598
[No Abstract] [Full Text] [Related]
10. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1.
Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K
Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590
[TBL] [Abstract][Full Text] [Related]
11. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
12. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
14. [Effects of estrogen on P-Tau, ChAT and nerve growth factor protein expressions in the brain tissue of rats with Alzheimer's disease].
Huagn Y; Xu YM; Zhang JW; Ren XH; Suo AQ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2408-10. PubMed ID: 20965859
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease. A new take on tau.
Marx J
Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561
[No Abstract] [Full Text] [Related]
16. [Role of serine/threonine protein phosphatase in tau phosphorylation].
Hu ZH; Tian Q; Wang JZ
Sheng Li Ke Xue Jin Zhan; 2006 Apr; 37(2):173-4. PubMed ID: 16850630
[No Abstract] [Full Text] [Related]
17. Which is a better target for AD immunotherapy, A beta or tau?
Martin-Jones Z; Lasagna-Reeves C
Alzheimer Dis Assoc Disord; 2008; 22(2):111-2. PubMed ID: 18525281
[No Abstract] [Full Text] [Related]
18. Homocysteine induces tau hyperphosphorylation in rats.
Luo Y; Zhou X; Yang X; Wang J
Neuroreport; 2007 Dec; 18(18):2005-8. PubMed ID: 18007203
[TBL] [Abstract][Full Text] [Related]
19. Dynamic changes of phosphorylated tau in mouse hippocampus after cold water stress.
Feng Q; Cheng B; Yang R; Sun FY; Zhu CQ
Neurosci Lett; 2005 Nov; 388(1):13-6. PubMed ID: 16005567
[TBL] [Abstract][Full Text] [Related]
20. Tau and Alzheimer's disease: the long road to anti-tangle therapeutics.
Fillit HM; Refolo LM
J Mol Neurosci; 2002 Dec; 19(3):249-50. PubMed ID: 12540049
[No Abstract] [Full Text] [Related]
[Next] [New Search]
